Nucleix
Rehovot, Israel · Founded 2008 · $82.0M raised
- Headquarters
- Rehovot
- Employees
- 51–200
- Founded
- 2008
- Website
- nucleix.com
- Total Funding
- $82.0M
- Last Round
- $55.0M Venture RoundApr 2021
- Rounds
- 3
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
Indexed holds 3 funding rounds and 5 investors for this company. The full record is or through the API.
About
Nucleix is a liquid biopsy company revolutionizing cancer treatment with earlier disease detection, at a time when intervention can bring the greatest impact for patients. Leveraging PCR-based epigenetics, our pioneering testing approach uses methylation-based identification for early-stage and recurring cancer detection.
Summary
Nucleix is a Biotech company based in Rehovot, Israel, founded in 2008. It has raised $82.0M in total across 3 rounds, most recently a $55.0M Venture Round in Apr 2021. Investors include RA Capital Management, OrbiMed and BlackRock.
Tech & App Stack
5 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Apr 2021
Sign up to see all 3 events
Funding: Seed through Venture Round. Amounts, valuations, and investors where available.
Investors
Similar Companies
China's leading blood products manufacturer
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Global contract research organization providing comprehensive drug development and laboratory ser...
Specialty pharmaceutical company
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/nucleix"><img src="https://indexed.vc/api/badge/company/nucleix" alt="Nucleix on Indexed.vc" width="260" height="76" /></a>